A detailed history of Sg Americas Securities, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 18,285 shares of COLL stock, worth $548,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,285
Previous 16,815 8.74%
Holding current value
$548,550
Previous $541,000 30.68%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$31.4 - $39.07 $46,158 - $57,432
1,470 Added 8.74%
18,285 $707,000
Q2 2024

Jul 12, 2024

BUY
$31.36 - $39.99 $87,337 - $111,372
2,785 Added 19.85%
16,815 $541,000
Q1 2024

May 06, 2024

SELL
$31.23 - $40.91 $131,603 - $172,394
-4,214 Reduced 23.1%
14,030 $545,000
Q4 2023

Jan 12, 2024

BUY
$21.16 - $30.8 $176,453 - $256,841
8,339 Added 84.19%
18,244 $562,000
Q3 2023

Oct 13, 2023

BUY
$21.23 - $24.28 $210,283 - $240,493
9,905 New
9,905 $221,000
Q1 2023

Apr 28, 2023

BUY
$23.0 - $29.88 $562,856 - $731,223
24,472 New
24,472 $587,000
Q2 2022

Jul 29, 2022

SELL
$14.22 - $20.88 $140,536 - $206,357
-9,883 Reduced 57.17%
7,404 $131,000
Q1 2022

Apr 29, 2022

SELL
$17.2 - $22.5 $270,005 - $353,205
-15,698 Reduced 47.59%
17,287 $352,000
Q4 2021

Feb 07, 2022

SELL
$17.5 - $21.35 $100,730 - $122,890
-5,756 Reduced 14.86%
32,985 $616,000
Q3 2021

Nov 01, 2021

BUY
$17.75 - $25.39 $687,652 - $983,633
38,741 New
38,741 $765,000
Q2 2021

Aug 12, 2021

SELL
$21.74 - $25.28 $215,617 - $250,727
-9,918 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$19.25 - $26.1 $190,921 - $258,859
9,918 New
9,918 $235,000
Q3 2020

Nov 09, 2020

SELL
$15.78 - $20.82 $323,395 - $426,685
-20,494 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$15.49 - $23.51 $130,859 - $198,612
8,448 Added 70.13%
20,494 $359,000
Q1 2020

Apr 30, 2020

BUY
$13.89 - $25.45 $83,201 - $152,445
5,990 Added 98.91%
12,046 $197,000
Q4 2019

Jan 28, 2020

BUY
$10.7 - $22.24 $64,799 - $134,685
6,056 New
6,056 $125,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.02B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.